Avian influenza (WHO)
World Health Organization (WHO) situation updates for Avian influenza. WHO is the directing and coordinating authority for health within the United Nations system. It is responsible for providing leadership on global health matters, shaping the health research agenda, setting norms and standards, articulating evidence-based policy options, providing technical support to countries and monitoring and assessing health trends.
-
Nationwide Utilization of Danish Government Electronic Letter System for Confirming the Effectiveness of Behavioral Nudges in Increasing InFLUenza Vaccine Uptake Among Older Adults
Sep 11, 2023 | 18:00 pmConditions: Influenza; Behavior and Behavior MechanismsIntervention: Behavioral: Behavioral Economic PrinciplesSponsor: Tor Biering-SørensenRecruiting
-
Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years
Sep 8, 2023 | 18:00 pmConditions: Influenza; Community-acquired Pneumonia; Cardiovascular EventsInterventions: Biological: Adjuvanted Quadrivalent Inactivated Influenza Vaccine (aIIV4); Biological: High-Dose Quadrivalent Inactivated Influenza Vaccine (HD-IIV4)Sponsors: Kaiser Permanente; SeqirusRecruiting
-
Cost-effectiveness of the Influenza Vaccination
Aug 18, 2023 | 18:00 pmConditions: Influenza Vaccine; Cost-Effectiveness; VaccinationIntervention: Drug: Quadrivalent Influenza VaccineSponsors: International Centre for Diarrhoeal Disease Research, Bangladesh; Centers for Disease Control and Prevention; Institute of Epidemiology, Disease Control and Research; Rajshahi Medical College Hospital, Rajshahi , Bangladesh; Khulna Medical College Hospital, Khulna, Bangladesh; Jalalabad Ragib-Rabeya Medical College & Hospital, Sylhet, BangladeshRecruiting
-
High vs.Standard Dose Influenza Vaccine in Pediatric SOT Recipients
Jul 17, 2023 | 18:00 pmConditions: Immunization; Infection; Transplantation Infection; InfluenzaInterventions: Biological: Standard Dose Quadrivalent Inactivated Influenza Vaccine; Biological: High Dose Quadrivalent Inactivated Influenza VaccineSponsors: Vanderbilt University Medical Center; Children's Hospital Medical Center, Cincinnati; Lucile Packard Children's Hospital; University of Pittsburgh; Ann & Robert H Lurie Children's Hospital of Chicago; Baylor College of Medicine; Children's Mercy Hospital Kansas City; Children's Healthcare of AtlantaNot yet recruiting
-
The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
Apr 27, 2023 | 18:00 pmCondition: InfluenzaInterventions: Other: Existing Influenza Vaccination Practices; Other: Standardized inpatient influenza vaccination programSponsors: University of Colorado, Denver; Agency for Healthcare Research and Quality (AHRQ); Seattle Children's HospitalNot yet recruiting
-
Influenza Vaccine Uptake Among Healthcare Workers
Aug 30, 2022 | 18:00 pmCondition: Influenza VaccinesIntervention: Behavioral: ensuring the availability of influenza vaccine supply & developing influenza vaccine awarenessSponsors: International Centre for Diarrhoeal Disease Research, Bangladesh; Institute of Epidemiology, Disease Control and Research; Sylhet M.A.G.Osmani Medical College; Mymensingh Medical College Hospital; Rajshahi Medical College; Khulna Medical College Hospital; Centers for Disease Control and PreventionRecruiting
-
Influenza Human Challenge Model
Apr 18, 2022 | 18:00 pmCondition: InfluenzaIntervention: Biological: Influenza Virus Type A H3N2 ChallengeSponsor: Emory UniversityRecruiting
-
High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
Jan 31, 2022 | 18:00 pmConditions: Immunization; Infection; Transplantation Infection; InfluenzaInterventions: Biological: High Dose Quadrivalent Inactivated Influenza Vaccine; Biological: Standard Dose Quadrivalent Inactivated Influenza VaccineSponsors: Vanderbilt University Medical Center; Northwestern University Feinberg School of Medicine; University of Alabama at Birmingham; University of Washington; Duke UniversityRecruiting
-
A Clinical Trial of an Inactivated Quadrivalent Influenza Vaccine in Chinese Children Aged 3 to 8 Years
Dec 3, 2021 | 18:00 pmCondition: InfluenzaIntervention: Biological: Quadrivalent influenza vaccineSponsors: Jiangsu Province Centers for Disease Control and Prevention; Jiangsu Jindike Biotechnology Co., Ltd.Enrolling by invitation
-
Characterization of Humoral and Cellular Immune Responses Elicited by Influenza Vaccination in Healthy Adults
Nov 5, 2021 | 17:00 pmCondition: Influenza, HumanIntervention: Biological: Seasonal influenza vaccineSponsors: University of Pennsylvania; National Institute of Allergy and Infectious Diseases (NIAID); Stanford University; The Scripps Research InstituteRecruiting
-
Efficacy of Different Doses of Influenza Vaccine in Chronic Hemodialysis Patients
Oct 7, 2021 | 18:00 pmConditions: ESRD; Influenza Vaccine; SeroprotectionIntervention: Biological: Egg-derived standard dose trivalent influenza vaccine (surface antigen, inactivated)Sponsors: Mahidol University; Bhumirajanagarindra Kidney Institute, Thailand; Ministry of Health, ThailandRecruiting
-
Broadening Our Understanding of Early Versus Late Influenza Vaccine Effectiveness
Sep 30, 2020 | 18:00 pmConditions: Influenza; Influenza -Like IllnessIntervention: Biological: Influenza vaccination at different time pointsSponsors: University of Leicester; Sanofi Pasteur, a Sanofi Company; World Health Organization; University of Warwick; University Hospitals, LeicesterCompleted
-
Nasal and Systemic Immune Responses to Nasal Influenza Vaccine
Oct 1, 2019 | 18:00 pmConditions: Influenza; Vaccine Virus SheddingInterventions: Biological: Live attenuated influenza vaccine; Other: Vehicle controlSponsor: Imperial College Healthcare NHS TrustCompleted
-
Response to Inactivated Influenza Vaccine in Lymph Tissue and Blood
Apr 2, 2019 | 18:00 pmCondition: InfluenzaIntervention: Biological: Quadrivalent inactivated influenza vaccine (IIV)Sponsors: Stanford University; National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID)Recruiting
-
Response to Influenza Vaccine During Pregnancy
Mar 25, 2019 | 17:00 pmCondition: InfluenzaIntervention: Biological: Quadrivalent inactivated influenza vaccine (IIV)Sponsors: Stanford University; National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID)Recruiting
-
Response to Live Attenuated Influenza Vaccine in Tonsillar Tissues and Blood
Mar 21, 2019 | 17:00 pmCondition: InfluenzaIntervention: Biological: FluMistSponsors: Stanford University; National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID)Recruiting
-
Improved Novel VaccIne CombinaTion InflUenza Study
Oct 3, 2017 | 18:00 pmCondition: InfluenzaInterventions: Drug: Seasonal influenza vaccine; Drug: MVA-NP+M1; Drug: Sodium chlorideSponsors: Vaccitech (UK) Limited; University of OxfordTerminated
-
Active Surveillance for Adverse Events Following Immunization With the Influenza Vaccine Produced at Butantan Institute
Feb 20, 2017 | 18:00 pmCondition: Influenza VaccinesIntervention: Biological: Seasonal Influenza vaccineSponsor: Butantan InstituteCompleted
-
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Sep 27, 2016 | 18:00 pmCondition: InfluenzaIntervention: Biological: Fluzone Quadrivalent vaccine, No PreservativeSponsor: Sanofi Pasteur, a Sanofi CompanyCompleted
-
Cohort Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza Vaccine
Jun 30, 2016 | 18:00 pmCondition: InfluenzaIntervention: Biological: Butantan Fragmented Inactivated Trivalent Influenza VaccineSponsor: Butantan InstituteCompleted
